MALONDIALDEHYDE VARIATIONS IN EXPERIMENTAL MYOCARDIAL INFARCTION


  • T. Timercan Nicolae Testemitsanu State University of Medicine and Pharmacy, Republic of Moldova
  • V. Timercan Nicolae Testemitsanu State University of Medicine and Pharmacy, Republic of Moldova
Keywords: cardiac ischemia, oxidative stress, lipid peroxidation, malondialdehyde

Abstract

MALONDIALDEHYDE VARIATIONS IN EXPERIMENTAL MYOCARDIAL INFARCTION

References

1. Jeroen Frijhoff, et al Clinical relevance of biomarkers of oxidative stress Antioxidants & Redox Signaling, 2015; 23; 14: 1144-1170

2. A. Negre-Salvayre, C. Coatrieux, C. Ungureanu, and R. Salvayre Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors British Journal of Pharmacology, 2008, 153: 6-20

3. Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes Mol Aspects Med, 2003; 24: 281- 291

4. Ramon Rodrigo, Matias Libuy, Felipe Feliu, and Daniel Hasson Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage Disease Markers, 2013; 35(4):773-790

5. Gudumac Valentin, Tagadiuc Olga, Nastas Ion Procedeu de dozare a dialdehidei malonice în ‒esutul osos. Certificat de inovator nr. 4366 din 15.11.2005 // Gudumac Valentin, Tagadiuc Olga, Nastas Ion Dosage procedure for malondialdehyde in bone tissue // Innovation certificate no. 4366 of 15.11.2005
Published
2018-11-15
How to Cite
Timercan, T., & Timercan, V. (2018). MALONDIALDEHYDE VARIATIONS IN EXPERIMENTAL MYOCARDIAL INFARCTION. Biological Markers in Fundamental and Clinical Medicine (collection of Abstracts), 2(2), 78-79. https://doi.org/10.29256/v.02.02.2018.escbm69
Section
Selected abstracts